Eduardo M Castaño
Eduardo M Castaño
Підтверджена електронна адреса в - Домашня сторінка
β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy
C Soto, EM Sigurdsson, L Morelli, RA Kumar, EM Castaño, B Frangione
Nature medicine 4 (7), 822-826, 1998
Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro.
T Wisniewski, EM Castano, A Golabek, T Vogel, B Frangione
The American journal of pathology 145 (5), 1030, 1994
Differences between vascular and plaque core amyloid in Alzheimer's disease
F Prelli, E Castano, GG Glenner, B Frangione
Journal of neurochemistry 51 (2), 648-651, 1988
The-helical to-strand transition in the amino-terminal fragment of the amyloid-peptide modulates amyloid formation
C Soto, EM Castaño, B Frangione, NC Inestrosa
Journal of Biological Chemistry 270 (7), 3063-3067, 1995
Hereditary cerebral hemorrhage with amyloidosis in patients of Dutch origin is related to Alzheimer disease
SG Van Duinen, EM Castano, F Prelli, GT Bots, W Luyendijk, B Frangione
Proceedings of the National Academy of Sciences 84 (16), 5991-5994, 1987
Fibrillogenesis in Alzheimer's disease of amyloid β peptides and apolipoprotein E
EM Castano, F Prelli, T Wisniewski, A Golabek, RA Kumar, C Soto, ...
Biochemical Journal 306 (2), 599-604, 1995
Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease
AE Roher, CL Esh, TA Kokjohn, EM Castaño, GD Van Vickle, WM Kalback, ...
Alzheimer's & Dementia 5 (1), 18-29, 2009
Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis.
F Coria, E Castano, F Prelli, M Larrondo-Lillo, S Van Duinen, ...
Laboratory investigation; a journal of technical methods and pathology 58 (4 …, 1988
Degradation of soluble amyloid β-peptides 1–40, 1–42, and the Dutch variant 1–40Q by insulin degrading enzyme from Alzheimer disease and control brains
A Pérez, L Morelli, JC Cresto, EM Castaño
Neurochemical research 25 (2), 247-255, 2000
In vitro formation of amyloid fibrils from two synthetic peptides of different lengths homologous to Alzheimer's disease β-protein
EM Castaño, J Ghiso, F Prelli, PD Gorevic, A Migheli, B Frangione
Biochemical and biophysical research communications 141 (2), 782-789, 1986
Human amyloidosis, Alzheimer disease and related disorders
EM Castano, B Frangione
Laboratory investigation 58 (2), 122-132, 1988
Defective ubiquitination of cerebral proteins in Alzheimer's disease
M López Salon, L Morelli, EM Castaño, EF Soto, JM Pasquini
Journal of neuroscience research 62 (2), 302-310, 2000
Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer's disease and non-demented elderly subjects
EM Castaño, AE Roher, CL Esh, TA Kokjohn, T Beach
Neurological research 28 (2), 155-163, 2006
Amyloid-β peptide remnants in AN-1792-immunized Alzheimer's disease patients: a biochemical analysis
RL Patton, WM Kalback, CL Esh, TA Kokjohn, GD Van Vickle, DC Luehrs, ...
The American journal of pathology 169 (3), 1048-1063, 2006
Ten to fourteen residue peptides of Alzheimer's disease protein are sufficient for amyloid fibril formation and its characteristic Xray diffraction pattern
PD Gorevic, EM Castano, R Sarma, B Frangione
Biochemical and biophysical research communications 147 (2), 854-862, 1987
Atherosclerosis, vascular amyloidosis and brain hypoperfusion in the pathogenesis of sporadic Alzheimer's disease
W Kalback, C Esh, EM Castaño, A Rahman, T Kokjohn, DC Luehrs, L Sue, ...
Neurological research 26 (5), 525-539, 2004
Fibrillogenesis of synthetic amyloid-β peptides is dependent on their initial secondary structure
C Soto, EM Castaño, RA Kumar, RC Beavis, B Frangione
Neuroscience letters 200 (2), 105-108, 1995
Brain amyloid in normal aging and cerebral amyloid angiopathy is antigenically related to Alzheimer's disease beta-protein.
F Coria, EM Castano, B Frangione
The American journal of pathology 129 (3), 422, 1987
The conformation of Alzheimer's β peptide determines the rate of amyloid formation and its resistance to proteolysis
Biochemical Journal 314 (2), 701-707, 1996
Physicochemical characteristics of soluble oligomeric Aβ and their pathologic role in Alzheimer's disease
D Watson, E Castaño, TA Kokjohn, YM Kuo, Y Lyubchenko, D Pinsky, ...
Neurological research 27 (8), 869-881, 2005
У даний момент система не може виконати операцію. Спробуйте пізніше.
Статті 1–20